J. Bishop

879 total citations
21 papers, 706 citations indexed

About

J. Bishop is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, J. Bishop has authored 21 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Hematology. Recurrent topics in J. Bishop's work include Lung Cancer Treatments and Mutations (5 papers), Acute Myeloid Leukemia Research (3 papers) and Blood transfusion and management (3 papers). J. Bishop is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Acute Myeloid Leukemia Research (3 papers) and Blood transfusion and management (3 papers). J. Bishop collaborates with scholars based in Australia, United States and Canada. J. Bishop's co-authors include K. Yuen, M. Wolf, Jeff Szer, Kathy McGrath, Ian Olver, Derek Raghavan, Richard Kaplan, Jane Matthews, George Morstyn and Joseph Aisner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J. Bishop

20 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Bishop Australia 11 331 241 231 126 112 21 706
Frank Peters Netherlands 13 425 1.3× 323 1.3× 40 0.2× 35 0.3× 76 0.7× 32 754
R T Silver United States 14 158 0.5× 87 0.4× 345 1.5× 55 0.4× 49 0.4× 24 620
Elena Pérez‐Ceballos Spain 13 107 0.3× 63 0.3× 236 1.0× 25 0.2× 63 0.6× 25 578
Andrew Belch United States 15 535 1.6× 108 0.4× 839 3.6× 75 0.6× 425 3.8× 32 1.1k
Marion Sternbach Canada 10 126 0.4× 50 0.2× 263 1.1× 21 0.2× 126 1.1× 17 529
Tzung‐Chih Tang Taiwan 14 146 0.4× 46 0.2× 216 0.9× 42 0.3× 147 1.3× 33 507
Jeffry B. Lawrence United States 10 58 0.2× 98 0.4× 146 0.6× 51 0.4× 49 0.4× 15 468
Ji Hyun Lee South Korea 11 331 1.0× 162 0.7× 94 0.4× 9 0.1× 83 0.7× 49 544
Tung‐Liang Lin Taiwan 15 194 0.6× 40 0.2× 394 1.7× 39 0.3× 214 1.9× 33 769
G. Salerno Italy 13 197 0.6× 53 0.2× 119 0.5× 11 0.1× 78 0.7× 20 552

Countries citing papers authored by J. Bishop

Since Specialization
Citations

This map shows the geographic impact of J. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bishop more than expected).

Fields of papers citing papers by J. Bishop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bishop. The network helps show where J. Bishop may publish in the future.

Co-authorship network of co-authors of J. Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bishop. A scholar is included among the top collaborators of J. Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bishop. J. Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ball, David, Ron Borland, Jai Smith, et al.. (2000). The influence of pretreatment optimism on outcome in patients given radical radiotherapy for non-small cell lung cancer. Lung Cancer. 29(1). 173–173. 6 indexed citations
2.
Zalcberg, John, M.J. Millward, J. Bishop, et al.. (1998). Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(5). 1948–1953. 81 indexed citations
3.
Millward, Michael, J. Bishop, Michael Friedländer, et al.. (1996). Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 14(1). 142–148. 61 indexed citations
4.
Bishop, J.. (1996). Does it matter how remission is achieved in acute leukemia?. PubMed. 10 Suppl 1. S7–9. 1 indexed citations
5.
Apostolopoulos, Vasso, et al.. (1995). The immunogenicity of MUC1 peptides and fusion protein. Cancer Letters. 90(1). 21–26. 21 indexed citations
6.
Bleehen, N. M., David Ball, Chandra P. Belani, et al.. (1994). Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. Lung Cancer. 10. S19–S23. 7 indexed citations
7.
Bishop, J., Jane Matthews, K. Yuen, et al.. (1993). Percentage increment measurements following platelet transfusions. Transfusion Medicine. 3(1). 92–93. 1 indexed citations
8.
Bishop, J., JP Matthews, K. Yuen, et al.. (1992). The definition of refractoriness to platelet transfusions. Transfusion Medicine. 2(1). 35–41. 51 indexed citations
9.
Ngan, Sam, David Ball, Colin A. Bull, et al.. (1991). Limited small cell lung cancer: The effect of radiotherapy on local control following response to chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 21(2). 459–462. 5 indexed citations
10.
Bishop, J., Jane Matthews, Kathy McGrath, et al.. (1991). Factors influencing 20‐hour increments after platelet transfusion. Transfusion. 31(5). 392–396. 87 indexed citations
11.
Raghavan, Derek, et al.. (1990). Phase II trial of carboplatin in the management of malignant mesothelioma.. Journal of Clinical Oncology. 8(1). 151–154. 67 indexed citations
12.
Bishop, J., et al.. (1989). A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion. Cancer Chemotherapy and Pharmacology. 24(4). 246–50. 8 indexed citations
13.
Olver, Ian, et al.. (1988). A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.. Journal of Clinical Oncology. 6(11). 1732–1735. 80 indexed citations
14.
McGrath, Kathy, M. Wolf, J. Bishop, et al.. (1988). Transient platelet and HLA antibody formation in multitransfused patients with malignancy. British Journal of Haematology. 68(3). 345–350. 41 indexed citations
15.
Bishop, J., Derek Raghavan, R. Stuart‐Harris, et al.. (1987). Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.. Journal of Clinical Oncology. 5(10). 1574–1578. 88 indexed citations
16.
Bishop, J., et al.. (1987). Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma. Cancer Chemotherapy and Pharmacology. 19(4). 326–30. 29 indexed citations
17.
Bishop, J., P H Wiernik, Margaret N. Wesley, et al.. (1987). A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphoma.. PubMed. 1(6). 508–13. 9 indexed citations
18.
Olver, Ian, et al.. (1983). ADRIAMYCIN COMBINATIONS AS SALVAGE THERAPY IN ADVANCED MOPP‐RESISTANT HODGKIN'S DISEASE. Australian and New Zealand Journal of Medicine. 13(4). 369–373. 3 indexed citations
19.
Bishop, J., et al.. (1982). Immunotherapy Maintenance in Acute Non-Lymphocytic Leukaemia. Australian and New Zealand Journal of Medicine. 12(6). 583–589. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026